Volume : 11, Issue : 08, August – 2024
Title:
FORMULATION AND EVALUATION OF KETOROLAC MUCOADHESIVE BUCCAL TABLETS
Authors :
Rambabu Sahu, Shailendra Kumar Modi
Abstract :
The main objective of present work is formulation and evaluation of ketorolac mucoadhesive buccal tablets. The buccal tablets were tested for weight uniformity, thickness, friability and hardness. Tablets were then evaluated for their swelling index, in vitro drug release, mucoadhesion time (wash-off time) and ex vivo drug permeation. The kinetics and mechanism of the drug permeation through the excised buccal tissue of goat from the buccal tablets were also characterized. The data collected were then analyzed using software to determine the effects of each parameter. The effects of the various parameters involved were then interpreted. The best polymer composite was selected from the various ratios of the polymers. The mucoadhesive strength of buccal tablets increases as the concentration of secondary polymer increases. The above polymer composite had shown satisfactory results in the parameters such as thickness, hardness, drug content, swelling index, mucoadhesive time, in-vitro dissolution and in-vitro diffusion. The satisfactory formulation shows a zero order drug release profile depending on the regression value and shown a satisfactory dissolution profile. The oral cavity and its highly permeable mucosal tissues have been taken advantage for decades as a site of absorption for delivery of drugs to the systemic circulation. So the formulations which target the oral cavity through buccal mucosa are of considerable interest to improve the bioavailability and reduce the frequency of administration of APIs. Drugs administered through the buccal route have a rapid onset of action and leads to improved bioavailability of drugs. The buccal route can by pass the first-pass metabolism, by pass contact of the drugs with the gastrointestinal fluids and paves way for easy access to the membrane sites so that the delivery system can be applied, localized and removed easily. Furthermore, there is good potential for prolonged delivery through the mucosal membrane within the oral mucosal cavity. Buccal adhesive systems offer innumerable advantages in terms of accessibility, administration and withdrawal, retentivity, low enzymatic activity, economy and high patient compliance.
Keywords: Drug, Evaluation, Metabolism, Bioavailability, Swelling index.
Cite This Article:
Please cite this article in press Rambabu Sahu et al., Formulation And Evaluation Of Ketorolac Mucoadhesive Buccal Tablets., Indo Am. J. P. Sci, 2024; 11 (08).
Number of Downloads : 10
References:
1. Shojaei A H. Buccal mucosa as a route for systemic drug delivery: a review. J Pharm Pharmaceut Sci, 1998; 1(4): 15-30.
2. Radha Bhati, Raja K Nagrajan. A detailed review on oral mucosal drug delivery system. Int J Pharm Sci Res. 2012; 3(3): 659-681.
3. https://en.wikipedia.org/wiki/Buccal_administration (last accessed on May 8, 2019)
4. Gilhotra RM, Ikram M, Srivastava S, Gilhotra N. A clinical perspective on mucoadhesive buccal drug delivery systems. J Biomed Res. 2014;28(2):81–97.
5. Shaikh R, TRR Singh, Garland MJ, Woolfson AD, Donnell RF. Mucoadhesive drug delivery systems. J Pharm Bio allied Sci. 2011; 3(1): 89–100.
6. Roy S, Pal K, Anis A, Pramanik K, Prabhakar B, Polymers in mucoadhesive drug delivery system: a brief note, Des. Monomers Polym. 2009; 3(12): 483–489.
7. Sudhakar Y, Kuotsu K, Bandyopadhyay AK, Buccal bioadhesive drug delivery: a promising option for orally less efficient drugs. J Control Release. 2006; 11(9): 15–40.
8. Lieberman HA, Lachman, Schwartz B. Pharmaceutical Dosage forms: Tablets Volume 1. 2nd ed. New York: Marcel Dekker; 1989.
9. Parth S Patel, Ashish M Parmar, Nilang S Doshi, Hardik V Patel, Raxit R Patel. Buccal drug delivery system: a review. Int J Drug Dev Res. 2013; 5(3): 35-48.
10. Patil SB, Murthy RSR, Mahajan HS, Wagh RD, Gattani SG. Mucoadhesive polymers: means of improving drug delivery. Pharma Times. 2006; 38(4): 25-28.
11. https://www.ncbi.nlm.nih.gov/pubmed/1494990 (lastaccessedonMay9,2019)
12. Burak Celik. Risperidone mucoadhesive buccal tablets: formulation design, optimization and evaluation. Drug Des Devel Ther. 2019; 11(3): 3355-3365.
13. https://www.drugs.com/pro/ketorolac.html (lastaccessedon Oct 8,2019)
14. https://en.wikipedia.org/wiki/Ketorolac (last accessedon Oct 7,2019)
15. Rupinder Kaur, Sukhdev Singh, Aaliya Hasan, Sunny Jalhan, Upendra K Jain. Development and evaluation of UV spectrophotometric method for the estimation of ketorolac tromethamine in bulk drug. World J Pharm Pharm Sci. 2016; 5(4): 1792-1799.
16. Rowe RC, Sheskey PJ, Weller PJ. Handbook of pharmaceutical excipients. 5th ed. UK. Pharmaceutical press. 2003; 298, 430, 617, 821.
17. Raghavendra N Rao, Shravani B, Mettu Srianth Reddy. Over view on buccal drug delivery systems: J Pharm Sci Res. 2013; 5(4): 80-88.
18. Marwa Shukar, Amal Abdel Reheem. Development and evaluation of ketorolac mucoadhesive buccal tablets; Int J Pharm Pharm Sci. 2014; 6(8): 294- 298.
19. Raja Navamani subramanian, Raghunandan Nerella, Chamundeeswari Duraipandian, Shanmuganathan Seetharaman. Quality by design approach for optimization ofrepaglinide buccal tablets using box behnken design. Future Journal of Pharmaceutical Sciences. 2018; 4(2): 265-272.
20. Patel Sweety, Anuradha Patel, Sachin Narkhede. Formulation evaluation and optimization of buccal tablets of ivabradine hydrochloride. J Pharm Sci Bio Scientific Res. 2016; 6(3): 329-337.
21. Hardik Parmar, Biswajit Biswal, Jyotiranjan Nayak. Design development and evaluation of buccal tablet containing nicorandil. Asian J Pharm Clin Res. 2015; 8(2): 102- 106.